ArticleFrontiers in pharmacology2016

Gypenoside Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of Mitogen-Activated Protein Kinase Mediated Nuclear Factor Kappa B Pathway In Vitro and In Vivo.

Haijie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.